OTN Specialty Services | Oncology Products

Products

OTN Specialty Services provides comprehensive specialty pharmacy services to oncology practices and their patients
Oral and Self-Injectable Medication Home Delivery Program

OTN Specialty Services offers cancer patients a comprehensive home delivery service that provides safe, controlled access to medications. We support patients throughout their regimen by confirming delivery and receipt of medications, contacting the patient when refills are necessary and providing our patients access to our pharmacists 24 hours a day, 7 days a week. We also partner with oncology practices by managing the medication benefit process and providing physicians with monthly patient compliance reports.

OTN Specialty Services offers competitive pricing! To obtain a quote on medications, simply click on icare Live Help OR contact an OTN Specialty Services representative via icare, email or by calling 1-800-370-2510 .

Below is a partial listing of our products.

Oral cancer agents:

Description	FDA Indication
Alkeran® (Melphalan) Alkylating agents, Nitrogen mustards	Ovarian cancer, multiple myeloma
Arimidex® (Anastrozole) Hormones, Aromatase inhibitors	Breast cancer
Aromasin® (Exemestane) Hormones, Aromatase inhibitors	Breast cancer
Casodex™ (Bicalutamide) Hormones, Antiandrogens	Prostate cancer
CeeNU® (Lomustine) Alkylating agents, Nitrosoureas	Brain tumors, Hodgkin's lymphoma
Cytoxan® (Cyclophosphamide) Alkylating agents, Nitrogen mustards	non-Hodgkin's lymphoma and Hodgkin's lymphoma, leukemia, breast cancer, multiple myeloma, Neuroblastoma, Retinoblastoma, Mycosis Fungoides (cutaneous T-cell lymphoma), ovarian cancer
Emcyt® (Estramustine) Alkylating agents, Estrogen/Nitrogen mustards	Prostate cancer
Ergamisol® (Levamisole) Biological response modifiers	Colorectal cancer
Eulexin® (Flutamide) Hormones, Antiandrogens	Prostate cancer
Fareston® (Toremifene) Hormones, Antiestrogens	Breast cancer
Femara® (Letrozole) Hormones, Aromatase inhibitors	Breast cancer
Gleevec® (Imatinib) Protein-Tyrosine Kinase inhibitors	Chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST)
Hexalen® (Altretamine) Alkylating agents, ethylenimines/methylamines	Ovarian cancer
Hydrea® (Hydroxyurea) Substituted ureas	Melanoma; resistant chronic myelocytic leukemia; recurrent, metastatic, or inoperable carcinoma of the ovary. Head and neck cancer
Leukeran® (Chlorambucil) Alkylating agents, Nitrogen mustards	Chronic lymphatic (lymphocytic) leukemia (CLL), malignant lymphomas including lymphosarcoma, giant follicular lymphoma and Hodgkin's lymphoma
Lysodren® (Mitotane) Miscellaneous	Adrenal cortical carcinoma
Matulane® (Procarbazine) Mehtylhydrazine	Hodgkin's lymphoma
Megestrol(Generic) Hormone Progestine	Breast or Endometrial Cancer
Myleran® (Busulfan) Alkylating agents, Alkyl sulfonates	Chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia (CML)
Nexavar® (Sorafenib)	Kidney cancer
Nilandron® (Nilutamide) Hormones, Antiandrogens	Prostate cancer
Purinethol® (Mercaptopurine) Antimetabolites, Purine analogs	Acute lymphatic (lymphocytic, lymphoblastic) leukemia, Acute myelogenouse (and acute myelomonocytic) leukemia
Revlimid® (Lenalidomide) Immunomodulators	Multiple myeloma. Transfusion-dependent anemia due to low-or-intermediate-1-risk myelodysplastic syndromes.
Soltamox® (Tamoxifen Citrate) Hormones, Antiestrogens	breast cancer
Sprycel™ (Dasatinib)	chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy including imatinib. Dasatinib is also FDA approved for the treatment of adults with Philadelphia chromosone-positive acute lymphoblastic leukemia (Ph+ ALL)
Sutent® (Sunitinib) Multikinase inhibitor	Kidney cancer
Tabloid® (Thioguanine) Antimetabolites, Purine analogs	Acute nonlymphocytic leukemias
Tamoxifen Hormones, Antiestrogens	Breast cancer
Tarceva® (Erlotinib) Epidermal Growth Factor Receptor Inhibitors	non-small cell lung cancer and pancreatic cancer
Targretin® (Bexarotene) Retinoids	Cutaneous manifestations of cutaneous T-cell lymphoma (CTCL)
Temodar® (Temozolomide) Imidazotetrazine	Anaplastic astrocytoma, glioblastoma multiforme
Teslac® (Testolactone) Hormones, Androgens	Breast cancer
Thalomid® (Thalidomide) Antiangiogenetic Agents	Multiple myeloma Treatment and maintenance therapy for prevention and suppresion of Erythema Nosoum Leprosum
Trexall™ (Methotrexate) Alkylating Agents, Folic Acid Antagonists	Breast cancer, head and neck, advanced mycosis fungoides (cutaneous T-cell lymphoma) and lung cancer, particularly squamous cell and small cell types; in combination therapy in the treatment of advanced-stage non-Hodgkin's lynphomas (NHL)
VePesid® (Etoposide) Epipodophyllotoxins, Podophyllotoxins	Small cell lung cancer
Vesanoid® (Tretinoin) Retinoids	Acute promyelocytic leukemia
Xeloda® (Capecitabine) Antimetabolites, Pyrimidine analogs	Colorectal cancer, breast cancer

Supportive Care Agents:

Description	FDA Indication
Anzemet® (Dolasetron) Antiemetic agents, 5HT3 receptor antagonists	Prevention of nausea and vomiting associated with initial and repeat courses of emtogenic cancer chemotherapy, including high-dose cisplatin (injection only)
Decadron® (Dexamethasone) Glucocorticoids	For the palliative management of leukemias and lymphomas
Diphenhydramine(Generic) Anticholinergic agents	Control nausea and help patients sleep. Helps control itching.
Emend® (Aprepitant) Antiemetic agents	Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin.
Hydrocortisone(Generic) Glucocorticoids	Reduce swelling (inflammation) that causes cancer pain. Used with other drugs to control and prevent nausea and vomiting caused by chemotherapy.
Leucovorin(Generic) Folic Acid Derivative
Mesnex® (Mesna) Chemoprotective agents	Ifosfamide-induced hemorrhagic cystitis
Kytril® (Granisetron) Antiemetic agents, 5HT3 receptor antagonists	Prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation (oral only)
Prednisone(Generic) Glucocorticoids	Reduce swelling (inflammation) that causes cancer pain. Used with other drugs to control and prevent nausea and vomiting caused by chemotherapy.
Zofran® (Ondansetron) Antiemetic agents, 5HT3 receptor antagonists	Prevention of nausea and vomiting associated with initial and repeat courses of emtogenic cancer chemotherapy, including high-dose cisplatin; prevention of postoperative nausea or vomiting; prevention of nausea and vomiting associated with radiotherapy in patients receiving total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen(oral); prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50mg/m2 (oral).
Zyloprim® (Allopurinol) Purine analogs	Leukemia, lymphoma Prevention of uric acid nephropathy during vigorous therapy of neoplastic disease

*Note: The above list represents the most commonly prescribed medications and is not a comprehensive list of medications offered by OTN Specialty Services.

Free Next Day Delivery with all purchases.
Payment may be made COD or with MasterCard, Visa, American Express or Discover Cards.
For those patients with insurance benefits, we will bill insurance directly according to the plan benefits.

To obtain a quote on medications, contact an OTN Specialty Services representative via icare, email or by calling 1-800-370-2510